investordatabase.org

Two River

tworiver.com Direct investor

Two River founds, builds and incubates life science companies, investing its own capital alongside scientific founders and management teams. It provides capital, operational capability and corporate development support to its portfolio companies.

Two River is a venture studio headquartered in New York, United States. It invests directly in companies, in life sciences, oncology, immunotherapy and synthetic biology.

“Two River founds and invests its own capital into companies with strong intellectual property and proven leadership teams who have demonstrated prior success developing innovative technologies in the life sciences sector.”

— Two River, own website
Layer
Direct investor
Type
Venture studio
Stage
Not stated
Headquarters
New York, United States
Sectors
life sciences, oncology, immunotherapy, synthetic biology, chemical biology
How to reach it
Its contact page on its own site

Team, as Two River publishes it

  • Arie Belldegrun, MD Chairman & Partner
  • Joshua Kazam Partner
  • David Tanen Partner
  • Chris Wilfong Operating Partner
  • Nicole van de Leuv Principal
  • David Chang, MD, PhD Venture Partner
  • Sean Algeo Chief Financial Officer
  • Owen Witte, MD Advisor
  • James S. Economou, MD, PhD University of California, Los Angeles (UCLA)

Names and roles exactly as listed on tworiver.com. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 8 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

Where this comes from

Every fact above was read from a page Two River publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 9181 · added 2026-09-29 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under